TickerFacts.

LB Pharmaceuticals Inc (LBRX): EPS (Diluted)

Annual figures by period end, from SEC filings.

-$3.13
Year ended 2025-12-31
2024-12-31: -$176.152025-12-31: -$3.13-$3.13
2024-12-31 EPS (Diluted) (USD per share) 2025-12-31
Period endedEPS (Diluted)Change YoYSource filing
2025-12-31-$3.13n/m2026-03-26, From 2025-01-01
2024-12-31-$176.15n/a2026-03-26, From 2024-01-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
LB Pharmaceuticals Inc (LBRX)2025-12-31-$3.13n/m
Atea Pharmaceuticals, Inc. (AVIR)2025-12-31-$1.94n/m
ADC Therapeutics SA (ADCT)2025-12-31-$1.12n/m
Omeros Corp (OMER)2025-12-31-$0.05n/m
Sionna Therapeutics, Inc. (SION)2025-12-31-$1.88n/m
Prothena Corp Public Ltd Co (PRTA)2025-12-31-$4.53n/m
ARS Pharmaceuticals, Inc. (SPRY)2025-12-31-$1.74n/m
Liquidia Corp (LQDA)2025-12-31-$0.80n/m
Cartesian Therapeutics, Inc. (RNAC)2025-12-31-$5.02n/m

Compare LBRX, AVIR, ADCT, OMER side by side · Screen every company in Pharmaceutical Preparations ↗